Literature DB >> 16733212

Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.

Pamela Pinzani1, Benedetta Salvadori, Lisa Simi, Simonetta Bianchi, Vito Distante, Luigi Cataliotti, Mario Pazzagli, Claudio Orlando.   

Abstract

The aim of this study is the counting and the immunomorphological and molecular characterization of circulating tumor cells (CTCs) by the isolation by size of epithelial tumor cells (ISET) method in the peripheral blood of patients with breast cancer. An evaluation of the method's ability to reveal the presence of occult carcinoma cells in blood of a patient with breast cancer was performed and the results compared with those obtained by quantitative real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay for the evaluation of cytokeratin-19 (CK-19) mRNA expression. The feasibility of molecular analysis of CTCs after laser microdissection of filters used in ISET was illustrated, referring to HER-2 amplification. Blood samples drawn from 44 patients with breast cancer were preoperatively analyzed by ISET. From the same samples, total RNA was extracted and submitted to quantitative real-time RT-PCR for the detection of CK-19 mRNA-positive cells using TaqMan technology. HER-2 amplification was measured by real-time RT-PCR on DNA extracted from cells recovered by laser microdissection from 7 selected ISET-positive filters. Of 44 samples, 12 (27%) showed the presence of epithelial cells on the filter (mean +/- SE: 8.5 +/- 2.4 cells per milliliter of blood). A statistically significant agreement (P = .001) was observed between real-time RT-PCR results and those obtained by ISET. With regard to HER-2 amplification, a good correspondence was found between the results obtained from microdissected CTCs and those obtained using DNA extracted from the primary tumor (R = 0.918; P < .01), as well as the immunohistochemistry results. The ISET method allows for the collection of breast carcinoma cells by filtration despite their smaller dimension relative to other carcinoma cell types. The sensitivity and specificity of the method is comparable with those obtained using the quantitative real-time RT-PCR assay for the evaluation of CK-19 mRNA expression. Moreover, the laser microdissection technique allows for the recovery of nucleic acids for further molecular analysis and CTC characterization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733212     DOI: 10.1016/j.humpath.2006.01.026

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  42 in total

Review 1.  Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells.

Authors:  Joshua M Jackson; Małgorzata A Witek; Joyce W Kamande; Steven A Soper
Journal:  Chem Soc Rev       Date:  2017-07-17       Impact factor: 54.564

2.  3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood.

Authors:  Siyang Zheng; Henry K Lin; Bo Lu; Anthony Williams; Ram Datar; Richard J Cote; Yu-Chong Tai
Journal:  Biomed Microdevices       Date:  2011-02       Impact factor: 2.838

3.  Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device.

Authors:  Giuseppe Galletti; Matthew S Sung; Linda T Vahdat; Manish A Shah; Steven M Santana; Giuseppe Altavilla; Brian J Kirby; Paraskevi Giannakakou
Journal:  Lab Chip       Date:  2013-11-07       Impact factor: 6.799

4.  Label-free isolation of circulating tumor cells in microfluidic devices: Current research and perspectives.

Authors:  Igor Cima; Chay Wen Yee; Florina S Iliescu; Wai Min Phyo; Kiat Hon Lim; Ciprian Iliescu; Min Han Tan
Journal:  Biomicrofluidics       Date:  2013-01-24       Impact factor: 2.800

Review 5.  CTC enumeration and characterization: moving toward personalized medicine.

Authors:  Angela Toss; Zhaomei Mu; Sandra Fernandez; Massimo Cristofanilli
Journal:  Ann Transl Med       Date:  2014-11

6.  Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.

Authors:  Katherine E Poruk; Vicente Valero; Tyler Saunders; Amanda L Blackford; James F Griffin; Justin Poling; Ralph H Hruban; Robert A Anders; Joseph Herman; Lei Zheng; Zeshaan A Rasheed; Daniel A Laheru; Nita Ahuja; Matthew J Weiss; John L Cameron; Michael Goggins; Christine A Iacobuzio-Donahue; Laura D Wood; Christopher L Wolfgang
Journal:  Ann Surg       Date:  2016-12       Impact factor: 12.969

7.  Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.

Authors:  Sophie Laget; Lucile Broncy; Katia Hormigos; Dalia M Dhingra; Fatima BenMohamed; Thierry Capiod; Magne Osteras; Laurent Farinelli; Stephen Jackson; Patrizia Paterlini-Bréchot
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

Review 8.  Blood-based tumor biomarkers in lung cancer for detection and treatment.

Authors:  Hirva Mamdani; Shahid Ahmed; Samantha Armstrong; Tony Mok; Shadia I Jalal
Journal:  Transl Lung Cancer Res       Date:  2017-12

9.  An automated high-throughput counting method for screening circulating tumor cells in peripheral blood.

Authors:  Mengxia Zhao; Perry G Schiro; Jason S Kuo; Karen M Koehler; Daniel E Sabath; Viorica Popov; Qinghua Feng; Daniel T Chiu
Journal:  Anal Chem       Date:  2013-02-06       Impact factor: 6.986

10.  Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy.

Authors:  Chun-Chao Chang; Shung-Haur Yang; Chih-Cheng Chien; Shu-Hung Chen; Shiann Pan; Chia-Long Lee; Chih-Ming Lin; Hsiao-Lun Sun; Chi-Cheng Huang; Yih-Yiing Wu; Ruey-Neng Yang; Chi-Jung Huang
Journal:  BMC Cancer       Date:  2009-10-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.